Proceedings: PET Drugs-A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit-Risk Considerations.

Bunning S, Christodoulou D, Cohen JE, Cutler CS, Dick DW, Ghosh K, Ignace C, Kasliwal RK, Lee H, Marzella L, Pohlhaus T, Scott PJH, Schwarz SW, Syed IA, VanBrocklin HF, Wasil LR, Zigler SS

Open source

DOI: 10.2967/jnumed.125.270011
Published: 2025 Sep 2
Container: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.125.270011,
  title = {Proceedings: PET Drugs-A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit-Risk Considerations.},
  author = {Bunning S and Christodoulou D and Cohen JE and Cutler CS and Dick DW and Ghosh K and Ignace C and Kasliwal RK and Lee H and Marzella L and Pohlhaus T and Scott PJH and Schwarz SW and Syed IA and VanBrocklin HF and Wasil LR and Zigler SS},
  year = {2025},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.125.270011},
  url = {https://doi.org/10.2967/jnumed.125.270011}
}

RIS

TY  - JOUR
TI  - Proceedings: PET Drugs-A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit-Risk Considerations.
AU  - Bunning S
AU  - Christodoulou D
AU  - Cohen JE
AU  - Cutler CS
AU  - Dick DW
AU  - Ghosh K
AU  - Ignace C
AU  - Kasliwal RK
AU  - Lee H
AU  - Marzella L
AU  - Pohlhaus T
AU  - Scott PJH
AU  - Schwarz SW
AU  - Syed IA
AU  - VanBrocklin HF
AU  - Wasil LR
AU  - Zigler SS
PY  - 2025
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.125.270011
UR  - https://doi.org/10.2967/jnumed.125.270011
ER  -

APA

S, B., D, C., JE, C., CS, C., DW, D., K, G., C, I., RK, K., H, L., L, M., T, P., PJH, S., SW, S., IA, S., HF, V., LR, W., & SS, Z. (2025). Proceedings: PET Drugs-A 2023 Workshop on Product Quality, Regulatory Submissions, Facility Inspections, and Benefit-Risk Considerations.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.270011

Source records

pubmed · retrieved 2026-09-26T16:14:24.370Z